Please Wait
Applying Filters...
menu
    • menu
    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    Kikkoman Biochemifa Company advances global health and safety through precision-driven innovation in biotech and food testing.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-10-20

    Virtual Booth

    An Enquiry

    Menu

    Nitric Oxide

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Biossil Acquire Galera Therapeutics' Dismutase Mimetics portfolio
    Biossil Acquire Galera Therapeutics' Dismutase Mimetics portfolio

    22 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/22/3170932/0/en/Galera-Therapeutics-Announces-Acquisition-of-Dismutase-Mimetics-Portfolio-by-Toronto-based-Biossil-for-up-to-105-Million.html

    GLOBENEWSWIRE
    22 Oct 2025
    Share Share
    Beyond Air Exercises Warrants for $3.25M Gross Proceeds
    Beyond Air Exercises Warrants for $3.25M Gross Proceeds

    08 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/08/3146420/0/en/Beyond-Air-Announces-Exercise-of-Warrants-for-3-25-Million-of-Gross-Proceeds.html

    GLOBENEWSWIRE
    08 Sep 2025
    Share Share
    Beyond Air Sets Q1 2026 Financial Results Call and Webcast
    Beyond Air Sets Q1 2026 Financial Results Call and Webcast

    25 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/25/3121752/0/en/Beyond-Air-Schedules-First-Fiscal-Quarter-2026-Financial-Results-Conference-Call-and-Webcast.html

    GLOBENEWSWIRE
    25 Jul 2025
    Share Share
    Beyond Air Granted U.S. Patent for NTM Infection Treatment
    Beyond Air Granted U.S. Patent for NTM Infection Treatment

    24 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/24/3067906/0/en/Beyond-Air-Granted-U-S-Patent-Covering-Treatment-of-NTM-Infections-Using-gaseous-Nitric-Oxide-gNO.html

    GLOBENEWSWIRE
    24 Apr 2025
    Share Share
    Beyond Cancer Receives Approval for Phase 1b Trial
    Beyond Cancer Receives Approval for Phase 1b Trial

    03 Dec 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/12/03/2991054/0/en/Beyond-Cancer-Announces-Approval-by-the-Israeli-Ministry-of-Health-to-Conduct-a-Phase-1b-Clinical-Trial-Utilizing-Low-Volume-Ultra-High-Concentration-Nitric-Oxide-LV-UNO-in-Combina.html

    GLOBENEWSWIRE
    03 Dec 2024
    Share Share
    Beyond Cancer Presents Preclinical LV UNO Therapy Data at SITC
    Beyond Cancer Presents Preclinical LV UNO Therapy Data at SITC

    11 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/11/2978200/0/en/Beyond-Cancer-Presents-Promising-Preclinical-Data-on-Low-Volume-Ultra-High-Concentration-Nitric-Oxide-LV-UNO-Therapy-at-the-2024-Society-for-Immunotherapy-of-Cancer-SITC-Annual-Mee.html

    GLOBENEWSWIRE
    11 Nov 2024
    Share Share